Ian H. Robertson, PhD, Chair in Psychology at Trinity College Dublin and author of The Winner Effect, wants to teach you how to be a winner. “The Winner Effect” is a…
Vinod Khosla, founder of Khosla Ventures, former CEO of Sun Microsystems, is a serial entrepreneur who has invested in a broad portfolio of healthtech startups. He discusses his views on…
Many patients experiencing depression prefer psychotherapy over taking antidepressant medications. However, around 75 percent of primary care patients who are diagnosed with depression experience barriers making it difficult…
NEW YORK (Reuters Health) – Monthly intramuscular injection of a depot formulation of aripiprazole delays the time to impending relapse in stabilized adults with schizophrenia, and has a…
NEW YORK (Reuters Health) – In patients with schizophrenia, chronic use of benzodiazepines is associated with an increased risk of death, whereas treatment with an antidepressant or several…
Robert Klitzman, MD, Professor of Clinical Psychiatry at the Columbia University Medical Center, discusses the advantages and disadvantages of full genome sequencing. With new advances and breakthroughs in…
NEW YORK (Reuters Health) – Despite widespread use of antipsychotics in children, evidence regarding the comparative benefits and harms of first-generation (FGAs) and second-generation antipsychotics (SGAs) are “limited,”…
NEW YORK (Reuters Health) – Pooled data suggest that nonsteroidal anti-inflammatory drugs (NSAIDs) can augment antipsychotic treatment and reduce schizophrenia symptom severity, Dutch researchers report in a December…
NEW YORK (Reuters Health) – Based on the 2010 American Diabetes Association’s definition of prediabetes, the condition is present in over a third of psychiatric inpatients treated with…
NEW YORK (Reuters Health) – More children with bipolar I disorder (manic or mixed phase) respond to the antipsychotic risperidone than to lithium or the anticonvulsant divalproex sodium,…